Modest revenue growth helps generic drug maker Teva swing to a third-quarter profit a day after its CEO Jeremy Levin resigned abruptly.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304527504579169494274856338.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304527504579169494274856338.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento